Published in Br J Clin Pharmacol on September 01, 1988
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma. Autophagy (2014) 1.84
Enantioselective disposition of hydroxychloroquine after a single oral dose of the racemate to healthy subjects. Br J Clin Pharmacol (1995) 1.43
Applying linear and non-linear methods for parallel prediction of volume of distribution and fraction of unbound drug. PLoS One (2013) 1.43
Bioavailability of hydroxychloroquine tablets in healthy volunteers. Br J Clin Pharmacol (1989) 1.36
Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate. Br J Clin Pharmacol (1993) 0.87
Inhibition of mTOR-dependent autophagy sensitizes leukemic cells to cytarabine-induced apoptotic death. PLoS One (2014) 0.81
Distribution of hydroxychloroquine in lymphoid tissue in a rabbit model for HIV infection. Antimicrob Agents Chemother (2013) 0.78
Absorption and in vivo dissolution of hydroxycholoroquine in fed subjects assessed using deconvolution techniques. Br J Clin Pharmacol (1993) 0.75
Development and Validation of Reversed-Phase High Performance Liquid Chromatographic Method for Hydroxychloroquine Sulphate. Indian J Pharm Sci (2016) 0.75
Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm (1978) 10.01
Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol (1983) 2.59
Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma. J Chromatogr (1983) 2.28
Chloroquine serum concentration and side effects: evidence for dose-dependent kinetics. Clin Pharmacol Ther (1979) 2.12
The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects. Eur J Clin Pharmacol (1984) 1.65
Spuriously low plasma propranolol concentrations resulting from blood collection methods. Clin Pharmacol Ther (1975) 1.46
On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther (1983) 1.34
The disposition of chloroquine in healthy Nigerians after single intravenous and oral doses. Br J Clin Pharmacol (1987) 1.11
Chloroquine and desethylchloroquine in plasma, serum, and whole blood: problems in assay and handling of samples. Ther Drug Monit (1985) 1.05
Comparison of the pharmacokinetics of chloroquine after single intravenous and intramuscular administration in healthy Africans. Br J Clin Pharmacol (1986) 1.03
High-performance liquid chromatographic assay for hydroxychloroquine and metabolites in blood and plasma, using a stationary phase of poly(styrene divinylbenzene) and a mobile phase at pH 11, with fluorimetric detection. J Chromatogr (1985) 1.03
Apparent dose-dependence of chloroquine pharmacokinetics due to limited assay sensitivity and short sampling times. Eur J Clin Pharmacol (1987) 1.00
Whole-blood single-dose kinetics of chloroquine and desethylchloroquine in Africans. Ther Drug Monit (1986) 0.90
Characteristics of chloroquine binding to glass and plastic. Am J Trop Med Hyg (1983) 0.89
Removal of an endogenous fluorescent compound from urine to allow quantitation of low concentrations of hydroxychloroquine and metabolites by high-performance liquid chromatography. J Chromatogr (1986) 0.87
Blood samples and chloroquine assay. Lancet (1983) 0.81
Further support for changes in chloroquine disposition and metabolism between a low and a high dose. Eur J Clin Pharmacol (1985) 0.80
Comparative analyses of multi-species sequences from targeted genomic regions. Nature (2003) 13.31
Nonsteroidal antiinflammatory drugs--differences and similarities. N Engl J Med (1991) 3.05
Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory Committee. Med J Aust (1996) 2.78
COX-2 inhibitors. Med J Aust (2000) 2.76
Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med (1994) 2.74
A crystalline fragment of the double helix: the structure of the dinucleoside phosphate guanylyl-3',5'-cytidine. Proc Natl Acad Sci U S A (1973) 2.39
Patterns of genetic variation in Mendelian and complex traits. Annu Rev Genomics Hum Genet (2000) 2.37
Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia. Intern Med J (2006) 2.19
Preventing acute gout when starting allopurinol therapy. Colchicine or NSAIDs? Med J Aust (1993) 2.09
RNA double-helical fragments at atomic resolution. II. The crystal structure of sodium guanylyl-3',5'-cytidine nonahydrate. J Mol Biol (1976) 2.07
Evaluation of the accuracy and reproducibility of ambulatory blood pressure monitoring in the very elderly using the Takeda TM-2420. J Hum Hypertens (1994) 1.92
Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. Clin Pharmacokinet (2000) 1.76
Copper-salicylate gel for pain relief in osteoarthritis: a randomised controlled trial. Med J Aust (1997) 1.66
Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of "responders" and "nonresponders". Arthritis Rheum (1997) 1.59
Vasoactive intestinal polypeptide (VIP) phase-shifts the rat suprachiasmatic nucleus clock in vitro. Eur J Neurosci (2001) 1.44
Overdose with chloral hydrate: a pharmacological and therapeutic review. Med J Aust (1989) 1.42
Wrong questions, wrong answers? Are we getting the drugs we need? Clin Pharmacol Ther (2012) 1.41
Does the availability of therapeutic drug monitoring, computerised dose recommendation and prescribing decision support services promote compliance with national gentamicin prescribing guidelines? Intern Med J (2015) 1.38
Bioavailability of hydroxychloroquine tablets in healthy volunteers. Br J Clin Pharmacol (1989) 1.36
Family-based association of FKBP5 in bipolar disorder. Mol Psychiatry (2008) 1.34
Effects of budesonide and fluticasone on 24-hour plasma cortisol. A dose-response study. Am J Respir Crit Care Med (1997) 1.28
Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol (2008) 1.27
Nucleic acid-mutagen interactions: crystal structure of adenylyl-3',5'-uridine plus 9-aminoacridine. Nature (1975) 1.20
RNA double helices generated from crystal structures of double helical dinucleoside phosphates. Biochem Biophys Res Commun (1976) 1.16
Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis. Clin Pharmacol Ther (1977) 1.15
The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box. Proc Nutr Soc (2000) 1.13
The evolution of an alpha-esterase pseudogene inactivated in the Drosophila melanogaster lineage. Mol Biol Evol (2000) 1.12
Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme? Intern Med J (2007) 1.11
Ultrafiltration in serum protein binding determinations. J Pharm Sci (1981) 1.07
The potential role of lysosomes in tissue distribution of weak bases. Biopharm Drug Dispos (1989) 1.05
Anabolic-androgenic steroids: medical assessment of present, past and potential users. Med J Aust (2000) 1.05
Anti-rheumatic drug interactions. Clin Rheum Dis (1984) 1.04
Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis--a cross sectional study. J Rheumatol (1993) 1.04
Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs--1. In vitro studies of ibuprofen and flurbiprofen. Biochem Pharmacol (1989) 1.03
High-performance liquid chromatographic assay for hydroxychloroquine and metabolites in blood and plasma, using a stationary phase of poly(styrene divinylbenzene) and a mobile phase at pH 11, with fluorimetric detection. J Chromatogr (1985) 1.03
The problems and pitfalls of NSAID therapy in the elderly (Part I). Drugs Aging (1991) 1.02
Numerical deconvolution by least squares: use of prescribed input functions. J Pharmacokinet Biopharm (1978) 1.00
Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis. Clin Pharmacol Ther (1982) 1.00
Apparent dose-dependence of chloroquine pharmacokinetics due to limited assay sensitivity and short sampling times. Eur J Clin Pharmacol (1987) 1.00
Variations in response to non-steroidal anti-inflammatory drugs. Br J Clin Pharmacol (1987) 0.99
Stereoselective disposition of ibuprofen and flurbiprofen in rats. Chirality (1990) 0.99
Theory of the mean absorption time, an adjunct to conventional bioavailability studies. J Pharm Pharmacol (1978) 0.99
The roles of vasoactive intestinal polypeptide in the mammalian circadian clock. J Endocrinol (2003) 0.99
Effects of vasoactive intestinal polypeptide on neurones of the rat suprachiasmatic nuclei in vitro. J Neuroendocrinol (2002) 0.98
Metformin therapy in patients with chronic kidney disease. Diabetes Obes Metab (2012) 0.96
Hemochromatosis heart disease: an unemphasized cause of potentially reversible restrictive cardiomyopathy. Am J Med (1980) 0.96
Corticosteroid injection for osteoarthritis of the knee: peripatellar compared to intra-articular route. Clin Exp Rheumatol (1990) 0.96
Diazepam plasma binding in the perinatal period: influence of nonesterified fatty acids. Eur J Clin Pharmacol (1982) 0.94
Binding of nonsteroidal anti-inflammatory agents to proteins--I. Ibuprofen-serum albumin interaction. Biochem Pharmacol (1979) 0.93
Simulation of kinetic data on the influx and efflux of chloroquine by erythrocytes infected with Plasmodium falciparum. Evidence for a drug-importer in chloroquine-sensitive strains. Biochem Pharmacol (1991) 0.92
6-Mercaptopurine-related leucopenia and in vivo xanthine oxidase activity. Lancet (1986) 0.92
Thrombosis: the major Hickman catheter complication in patients with solid tumor. Chest (1989) 0.92
Interactions between non-steroidal anti-inflammatory drugs and antihypertensives and diuretics. Aust N Z J Med (1986) 0.92
Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos. Proc Natl Acad Sci U S A (1995) 0.91
Transsynovial distribution of ibuprofen in arthritic patients. Clin Pharmacol Ther (1981) 0.91
Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects. Br J Clin Pharmacol (1996) 0.91
Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects. Biol Psychiatry (1997) 0.91
Displacement of tolbutamide, glibencalmide and chlorpropamide from serum albumin by anionic drugs. Biochem Pharmacol (1976) 0.90
Pharmacokinetics of non-steroidal anti-inflammatory drugs. Baillieres Clin Rheumatol (1988) 0.90
Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status? Intern Med J (2012) 0.89
The binding of sulphonylureas to serum albumin. J Pharm Pharmacol (1974) 0.89
Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide. Br J Pharmacol (2008) 0.89
Terminations of treatment with gold sodium thiomalate in rheumatoid arthritis. J Rheumatol (1983) 0.88
High-performance liquid chromatographic analysis of mometasone furoate and its degradation products: application to in vitro degradation studies. J Pharm Biomed Anal (2001) 0.88
A linear recirculation model for drug disposition. J Pharmacokinet Biopharm (1979) 0.87
Theoretical isotropic dissolution of nonspherical particles. J Pharm Sci (1976) 0.87
Role of lysosomes in hepatic accumulation of chloroquine. J Pharm Sci (1988) 0.87
Analgesic efficacy of non-steroidal anti-inflammatory drugs in experimental pain in humans. Br J Clin Pharmacol (1993) 0.87
Removal of an endogenous fluorescent compound from urine to allow quantitation of low concentrations of hydroxychloroquine and metabolites by high-performance liquid chromatography. J Chromatogr (1986) 0.87
Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate. Br J Clin Pharmacol (1993) 0.87
Validation of methods to study the distribution and protein binding of tacrolimus in human blood. J Pharmacol Toxicol Methods (2002) 0.87
Induction of salicyluric acid formation in rheumatoid arthritis patients treated with salicylates. Clin Pharmacokinet (1983) 0.87
Influence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalers. J Aerosol Med (1998) 0.86
Stereoselective disposition--basis for variability in response to NSAID's. Agents Actions Suppl (1985) 0.86
Captopril overdose. Med J Aust (1989) 0.86
Aspects of the clinical pharmacology of non-steroidal anti-inflammatory drugs. Clin Rheum Dis (1984) 0.86
Variability in response to NSAID. Agents Actions Suppl (1985) 0.86
Linear systems analysis in pharmacokinetics. J Pharmacokinet Biopharm (1978) 0.86
Identification of products from oxidation of uric acid induced by hydroxyl radicals. Free Radic Res Commun (1993) 0.86
Bioavailability of hydroxychloroquine tablets assessed with deconvolution techniques. J Pharm Sci (1992) 0.86
D-penicillamine and D-penicillamine-protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritis. Br J Clin Pharmacol (1990) 0.85
Access to tumour necrosis factor inhibitors for rheumatoid arthritis treatment under the Australian Pharmaceutical Benefits Scheme: are we on target? Intern Med J (2006) 0.85
The oncogenicity of chlorambucil in rheumatoid arthritis. Br J Rheumatol (1988) 0.84
Comparing dose prediction software used to manage gentamicin dosing. Intern Med J (2013) 0.84
The role and impact of research agendas on the comparative-effectiveness research among antihyperlipidemics. Clin Pharmacol Ther (2012) 0.84
High-performance liquid chromatographic separation of the enantiomers of hydroxychloroquine and its major metabolites in biological fluids using an alpha 1-acid glycoprotein stationary phase. J Chromatogr (1991) 0.84
Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: the role of endothelin-1. J Hum Hypertens (1996) 0.84
Classic Weinstein: tetrad analysis, genetic variation and achiasmate segregation in Drosophila and humans. Genetics (1999) 0.84
Electrophysiological actions of orexins on rat suprachiasmatic neurons in vitro. Neurosci Lett (2008) 0.84
Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis. J Rheumatol (1988) 0.84
Disposition and absorption of hydroxychloroquine enantiomers following a single dose of the racemate. Chirality (1994) 0.84